Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.

Effective immediately, the U.S. Food and Drug Administration has approved the use of Spravato (esketamine) nasal spray for the treatment of treatment-resistant depression, more commonly known as TRD.

The Struggle is Real.

You don't like taking antidepressants. They take too long to work. The side effects of this antidepressant are worse than the last one you tried. Is your depression treatment resistant?

Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.

What Did They Just Say!? 

Ketamine can help with Treatment Resistant Depression?